Familial dysbetalipoproteinaemia,chronic inflammatory arthropathy and diabetes mellitus causing premature peripheral vascular atherosclerosis

Mahley RW , Huang Y. , Rall SC Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinaemia). Questions, quandaries, and paradoxes. J Lipid Res 1999;40:1933-49.

Bagdade JD , Porte D. , Bierman EL Steroid induced lipemia. Arch Intern Med 1970 ;125:129-34.

Ballantyne CM , Podet EJ , Patch WP et al. Effects of cyclosporine therapy on lipoprotein levels. JAMA 1989;262:53-6.

Citkowitz E. , Friday KE Dysbetalipoproteinemia. eMedicine Specialties > Endocrinology > Metabolic Disorders. Updated 10 November 2009. http://emedicine.medscape.com/article. (Accessed 12 November 2009).

Knowles JW , Assimes TL , Li J. et al. Genetic susceptibility to peripheral arterial disease: a dark corner in vascular biology. Arterioscler Thromb Vasc Biol 2007;27:2068-78.

Libby P. , Ridker PM Inflammation and atherothrombosis: from population biology and bench research to clinical practice. J Am Coll Cardiol 2006 ;48:A33-A46.